A Study of TG103 in Subjects With Type 2 Diabetes

Clinical trial NCT04790006 · UNKNOWN

Trial details

NCT number: NCT04790006
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-04-01
Primary completion: 2022-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.